BioInformant

Your Global Leader in Stem Cell Market Research

Home » Stem Cells » MSCs » Page 57

Mesenchymal Stem Cells (MSCs)

Mesenchymal stem cells (MSCs) are a well-characterized population of adult stem cells that can differentiate into a variety of cell types (chondrocytes, osteoblasts, adipocytes, myocytes, and more).

Adult and Fetal Isolation Sources for Mesenchymal Stem Cells (MSCs)

By Leave a Comment

Mesenchymal stem cells can be derived from a diverse range of tissues. Originally, Friedenstein et al. isolated MSCs from the bone marrow (BM) and stroma of the spleen and thymus.[1][2] MSCs have since been derived from tissues as varied as the brain, spleen, liver, kidney, lung, bone marrow, muscle, thymus, and pancreas.[3]  However, bone marrow aspirates are still considered to be the most convenient and enriched source of MSCs.[4]

Fetal tissue also contains MSCs, with common sources including umbilical cord blood and fetal placenta. These sources may represent ontogenetically younger MSCs. Evidence exists that MSCs from fetal sources can undergo more cell divisions before they reach senescence than MSCs from adult tissue.[5] [Read more…]

Cord Blood Industry News Round-Up | May 2015

By Leave a Comment

The cord blood banking industry is well-known for its shifting dynamics, including new alliances, new research advances and innovations. Every month there are major new events that affect market participants.

While it may be possible to stay informed about cord blood industry news in your region, it can be more difficult to track changes on a global scale. For that reason, the following is a summary of significant cord blood industry events for May 2015. [Read more…]

Mesenchymal Stem Cell (MSC) Products – The Cost of Winning Search Terms Online

By Leave a Comment

Marketing Cost Analysis for “Mesenchymal Stem Cell”

Because Google now controls over 50% of online searches, it is the single best resource available for analyzing online search behavior within the mesenchymal stem cell (MSC) market.

Identifying the cost of winning search terms related to MSCs is an important analysis for company executives to conduct, because it allows for the planning of cost-effective Google AdWords campaigns and because it reveals existing levels of market competition for the sale of MSC products and services. [Read more…]

Major Industry Alliance: CariCord and ClinImmune Labs Partner with International Space Medicine Consortium

By Leave a Comment

AUTHOR: Authored by Wendy Roberts, PR Director of Orca Communications Unlimited, LLC.

COMMENT BY BIOINFORMANT:  Leading global players within cord blood industry frequently attain their industry dominance through industry collaborations.  In the announcement below, released May 11, 2015, CariCord and ClinImmune Labs announce a major industry partnership that will study the survivability of umbilical cord blood stem cells under micro gravity (Micro-G) simulation.

CariCord, a private stem cell bank at the University of Colorado, is a FDA-licensed cord blood manufacturer that has processed nearly 9,000 cord blood units and released 700+ for transplantation across 150+ hospitals worldwide.  While CariCord is not as substantial in size as other key players within the U.S. cord blood industry (most notably Cord Blood Registry, ViaCord, and Cryo-Cell, respectively) the company is positioning itself for increased visibility and growth through this strategic collaboration. [Read more…]

Cord Blood World Europe – Bringing together Public and Private Banks, Clinicians & Researchers

By 2 Comments

BioInformant is excited and proud to announce our sponsorship of the Cord Blood World Europe Congress 2015 as an essential global event for those participating within the cord blood and regenerative medicine community. BioInformant is deeply committed to advancing progress with human umbilical cord blood, because cord blood contains valuable hematopoietic stem cells and cord tissue (“Wharton’s Jelly”) contains valuable mesenchymal stem cells. 

As the first and only company dedicated to tracking the stem cell market, BioInformant tracks this important market segment within our global strategic report the “Complete 2015-16 Global Cord Blood Industry Report.” We also have an entire section of our blog dedicated to breaking cord blood industry news. Additionally, we have a partnership with the Save the Cord Foundation, a non-profit dedicated to cord blood banking awareness and education, in which we run a joint awareness campaign called “Cord Blood Banking Awareness: Educating America and the World.” The campaign is a global effort to educate currently expecting parents, as well as future parents, grandparents, siblings, and friends, about the medical benefits of cord blood preservation. [Read more…]

BioInformant's World-Class Clients